39
DAFTAR PUSTAKA
1. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2013; 36: 67–74.
2. PERKENI (2011). Konsensus Pengelolaan dan Pencegahan Diabetes Mellitus tipe 2 di Indonesia. Jakarta. PB PERKENI.
3. Okita K, Iwahashi H, Kozawa J, Okauchi Y, Funahashi T, Imagawa A, dkk. Homeostasis model assessment of insulin resistance for evaluating insulin sensitivity in patients with type 2 diabetes on insulin therapy. Endocrine Journal. 2013; 60(3): 283-290.
4. Taylor R. Insulin Resistance and Type 2 Diabetes. DIABETES. 2012; 61. 5. Tara MW, Jonathan C, David R. Use and Abuse of HOMA Modeling.
Diabetes Care. 2004; 27: 1487–1495,
6. Gayoso-diz P, Alfonso, Maria. Insulin resistance (HOMA-IR) cut-off values and the metabolic syndrome in a general adult population: effect of gender and age: EPIRCE cross-sectional study. BMC Endocrine Disorders. 2013, 13: 47. 7. Depkes RI. (2000). Inventaris Tanaman Obat Indonesia (I). Cetakan Pertama.
Jakarta: Departemen Kesehatan RI. Halaman 21-22.
8. Plant Resources of South-East Asia. 2012. Medicinal and poisonous 2. PRSEA. 2012; 12(2).
9. Harfina F, Bahri S, Saragih A. Pengaruh serbuk daun Puguntano (Curanga fel-terrae Merr.) pada pasien Diabetes Mellitus. Journal of Pharmaceutics and Pharmacology. 2012; 1 (2): 112-118.
10.Juwita NA. Pengujian efek antiinflamasi ekstrak etanol daun pugun tano (Curanga fel-terrae Merr.) terhadap mencit putih. Medan: Fakultas Farmasi USU. 2009.
11.SP3T. Uji antidiabetes dari daun pugun tano (Curanga fel-terrae Merr) yang digunakan masyarakat dairi secara preklinis. Sentra Pengembangan dan Penerapan Pengobatan Tradisional (SP3T). Medan. 2011.
12.Harahap U, Patilaya P, Mariane, dkk. Profil fitokimia ekstrak etanol daun puguntano [curanga fel-terrae (merr.) lour.] yang berpotensi sebagai antiasma. Seminar Nasional Sains & Teknologi V Lembaga Penelitian Universitas
Lampung. 2013.
40
13.Sitorus P, Harahap U, Pandapotan M, Barus T. Isolation of β-sitosterol from n-Hexane Extract of Picria fel-terrae Lour. Leave and Study of Its Antidiabetic Effect in Alloxan Induced Diabetic Mice. International Journal of PharmTech Research. 2014; 6(1): 137-141.
14.Wilcox G. Insulin and Insulin Resistance. Clin Biochem Rev. 2005 May. 2005; 26(2): 19-39.
15.Shulman GI. Cellular Mechanisms of Insulin Resistance. The Journal of Clinical Investigation. 2000; 106: 2.
16.Sheperd PR, Kahn BB. Glucose Transporter and Insulin Action. The New England Journal of Medicine. 1999.
17.Hui-Qi Qu, Quan Li, Fisher-Hoch. The definition of insulin resistance using homa-ir for americans of mexican descent using machine learning. PLOS ONE 2011; 6(6): e2104.
18.Subramanian V, Butler LG, Jambunathan R. Some agronomic and biochemical characters of brown sorghums and their possible role in bird resistance. J Agric Food Chem. 1983; 31: 1303-1307.
19.Pinent M, Blay M, Blade MC, Salvado MJ, Arola L, Arvedol A. Grape seedderived procyanidins have an antihyperglycemic effect in streptozotocin-induced diabetic rats and insulinomimetic activity in insulin- sensitive cell lines. Endocrinology. 2004; 145: 4985-4990.
20.Kao YH, Hiipakka RA, Liao S. Modulation of endocrine systems and food intake by green tea epigallocatechin gallate. Endocrinology. 2000; 141: 980-987.
21.Kim MJ, Ryu GR, Chung JS, Sim SS. Protective effects of epicatechin against the toxic effects of streptozotocin on rat pancreatic islets: in vivo and in vitro. Pancreas. 2003; 26: 292-299.
22.Anderson RA dan Polansky MM. Tea enhances insulin activity. J Agric Food Chem. 2002; 50: 7182-7186.
23.Bennick A. Interaction of plant polyphenols with salivary proteins. Crit Rev Oral Bio Me. 2002; 13: 184-196.
24.Kumari M dan Jain S. Tannins: An Antinutrient with Positive Effect to Manage Diabetes. Res J Recent Sci. 2012; 1(12): 70-73.
41
25.Fernandez SP, Wasowski C, Loscalzo LM, Granger RE, Johnston GA, Paladini AC, et al. Central nervous system depressant action of flavonoid glycosides. Eur J Pharmacol. 2006; 539(3): 168–176.
26.Patra JC dan Chua BH. Artificial neutral network based drug design for diabetes mellitus using flavonoids. J Comput Chem. 2010; 32(4): 555–567. 27.Mohan S dan Nandhakumar L. Role of various flavonoids: Hypotheses on
novel approach to treat diabetes. Journal of Medical Hypotheses and Ideas. 2013; 8: 1–6.
28.Brahmachari G. Bio-flavonoids with promising antidiabetic potentials: A critical survey. Opportunity, Challenge and Scope of Natural Products in Medicinal Chemistry. 2011: 187-212.
29.Matsuda H, Morikawa T, Yoshikawa M. Pure Appl. Chem. 2002; 74: 1301-1308.
30.Petrash JM. All in the family: aldose reductase and closely related aldo-keto reductases. Cell. Mol. Life Sci. 2004; 61(7-8): 737-749.
31.Pradip K , Vasumathi T , Marina K. Antidiabetic effect and mode of action of the triterpenoid, cddo-me, in diet-induced type 2 diabetic mice and lepr db/db mice. ADA. 2010: 1393-1397.
32.Atanasov AG, Wang JN, Gu SP, Bu J. A non-adipogenic PPARγ agonist from nature. Biochim Biophys Acta. 2013; 1830(10): 4813-4819.
33.Madiyono B. Perkiraan Besar Sampel dalam Dasar-dasar Metodologi Penelitian Klinis. Sastroasmoro S, Ismael S. Jakarta: Sagung Seto 2008; 16: 302-330.
34.Katsuki A, Sumida Y, Gabazza CE, Murashima S, Furuta M, Araki R. Homeostasis model assessment is a reliable indicator of insulin resistance during follow-up of patients with type 2 diabetes. Diabetes Care. 2001; 24: 362–365.
35.Rojas LBA, Gomes MB. Metformin: an old but still the best treatment for type 2 diabetes. Diabetology & Metabolic Syndrome. 2013; 5: 6.
36.Iliadis F, Kadoglou NP, Hatzitolios A, Karamouzis M, Alevizos M, Karamitsos D. Metabolic effects of rosiglitazone and metformin in Greek
42
patients with recently diagnosed type 2 diabetes. In vivo journal. 2007; 21: 1107-1114.
37.Ma J, Liu LY, Wu PH, Liao Y, Tao T, Liu W. Comparison of metformin and repaglinide monotherapy in the Treatment of new onset type 2 diabetes mellitus in china. Journal of Diabetes Research. 2014.
38.Krysiak R, Gdula-Dymek A, Okopien B. Effect of metformin on selected parameters of hemostasis in fenofibrate-treated patients with impaired glucose tolerance. Pharmacological Reports. 2013; 65: 208- 213.
39.Kadhim KA, Ismael DK, Khalaf BH, Husseiun KL, Zalzala MH, Hussain SA. Dose-dependent relationship between serum metformin levels and glycemic control, insulin resistance and leptin levels in females newly diagnosed with type 2 diabetes mellitus. Journal of Diabetes Mellitus. 2012; 2: 179-185.
